These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 27509881)

  • 41. Management of Rectal Cancer Without Radical Resection.
    Beets GL; Figueiredo NF; Beets-Tan RG
    Annu Rev Med; 2017 Jan; 68():169-182. PubMed ID: 27618750
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transanal Endoscopic Microsurgery (TEM) Following Neoadjuvant Chemoradiation for Rectal Cancer: Outcomes of Salvage Resection for Local Recurrence.
    Perez RO; Habr-Gama A; São Julião GP; Proscurshim I; Fernandez LM; de Azevedo RU; Vailati BB; Fernandes FA; Gama-Rodrigues J
    Ann Surg Oncol; 2016 Apr; 23(4):1143-8. PubMed ID: 26577119
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Rational evaluation of the complete response after neoadjuvant therapy in locally advanced mid-low rectal cancer: the pros and cons of "watch and wait" strategy].
    Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):507-513. PubMed ID: 31238630
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transanal endoscopic microsurgery after neoadjuvant radiochemotherapy for locally advanced extraperitoneal rectal cancer.
    Rizzo G; Zaccone G; Magnocavallo M; Mattana C; Pafundi DP; Gambacorta MA; Valentini V; Coco C
    Eur J Surg Oncol; 2017 Aug; 43(8):1488-1493. PubMed ID: 28583790
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemoradiation and consolidation chemotherapy for rectal cancer provides a high rate of organ preservation with a very good long-term oncological outcome: a single-center cohort series.
    Asoglu O; Bulut A; Aliyev V; Piozzi GN; Guven K; Bakır B; Goksel S
    World J Surg Oncol; 2022 Nov; 20(1):358. PubMed ID: 36352416
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current status and perspectives on "watch and wait" strategy for rectal cancer patients after clinical complete response following neoadjuvant chemoradiation].
    Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Jun; 22(6):521-526. PubMed ID: 31238632
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-operative management in low-lying rectal cancers undergoing chemoradiation.
    Datta D; Engineer R; Saklani A; D'souza A; Baheti A; Kumar S; Krishnatry R; Ostwal V; Ramaswamy A; Patil P
    J Cancer Res Ther; 2024 Jan; 20(1):417-422. PubMed ID: 38554355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Watch-and-Wait Compared to Operation for Patients with Complete Response to Neoadjuvant Therapy for Rectal Cancer.
    Beard BW; Rettig RL; Ryoo JJ; Parker RA; McLemore EC; Attaluri V
    J Am Coll Surg; 2020 Dec; 231(6):681-692. PubMed ID: 33121903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonoperative management after neoadjuvant therapy for rectal cancer: A single institution experience over 5 years.
    Strode M; Shah R; Boland PM; Francescutti VA; Mangieri CW; Attwood K; Nurkin SJ
    Surg Oncol; 2019 Mar; 28():116-120. PubMed ID: 30851884
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Locally advanced rectal cancer: Preliminary results of rectal preservation after neoadjuvant chemoradiotherapy.
    Vaccaro CA; Yazyi FJ; Ojra Quintana G; Santino JP; Sardi ME; Beder D; Tognelli J; Bonadeo F; Lastiri JM; Rossi GL
    Cir Esp; 2016 May; 94(5):274-9. PubMed ID: 26980259
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Observation of "complete clinical response" in rectal cancer after neoadjuvant chemoradiation: The Flinders experience.
    Sposato LA; Lam Y; Karapetis C; Vatandoust S; Roy A; Hakendorf P; Dwyer A; de Fontgalland D; Hollington P; Wattchow D
    Asia Pac J Clin Oncol; 2018 Dec; 14(6):439-445. PubMed ID: 29932278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selected stage IV rectal cancer patients managed by the watch-and-wait approach after pelvic radiotherapy: a good alternative to total mesorectal excision surgery?
    Custers PA; Hupkens BJP; Grotenhuis BA; Kuhlmann KFD; Breukink SO; Beets GL; Melenhorst J;
    Colorectal Dis; 2022 Apr; 24(4):401-410. PubMed ID: 35060263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer.
    Williams H; Omer DM; Thompson HM; Lin ST; Verheij FS; Miranda J; Yuval JB; Buckley J; Marco MR; Qin LX; Dombroski DA; Kedar R; Oto A; Korngold E; Veniero JC; Gandhi S; Krishnaraj A; Jagtiani M; Ohanian K; Vu D; Hope TA; Lee S; Wasnik AP; Madhuripan N; Gollub MJ; Garcia-Aguilar J;
    Radiology; 2024 Sep; 312(3):e232748. PubMed ID: 39225603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MRI and diffusion-weighted MRI to diagnose a local tumour regrowth during long-term follow-up of rectal cancer patients treated with organ preservation after chemoradiotherapy.
    Lambregts DM; Lahaye MJ; Heijnen LA; Martens MH; Maas M; Beets GL; Beets-Tan RG
    Eur Radiol; 2016 Jul; 26(7):2118-25. PubMed ID: 26518582
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chemoradiation therapy for rectal cancer in the distal rectum followed by organ-sparing transanal endoscopic microsurgery (CARTS study).
    Verseveld M; de Graaf EJ; Verhoef C; van Meerten E; Punt CJ; de Hingh IH; Nagtegaal ID; Nuyttens JJ; Marijnen CA; de Wilt JH;
    Br J Surg; 2015 Jun; 102(7):853-60. PubMed ID: 25847025
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Watch and wait policy after preoperative radiotherapy for rectal cancer; management of residual lesions that appear clinically benign.
    Rupinski M; Szczepkowski M; Malinowska M; Mroz A; Pietrzak L; Wyrwicz L; Rutkowski A; Bujko K
    Eur J Surg Oncol; 2016 Feb; 42(2):288-96. PubMed ID: 26506863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical Trial.
    Thompson HM; Omer DM; Lin S; Kim JK; Yuval JB; Verheij FS; Qin LX; Gollub MJ; Wu AJ; Lee M; Patil S; Hezel AF; Marcet JE; Cataldo PA; Polite BN; Herzig DO; Liska D; Oommen S; Friel CM; Ternent CA; Coveler AL; Hunt SR; Garcia-Aguilar J;
    JAMA Netw Open; 2024 Jan; 7(1):e2350903. PubMed ID: 38194231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rectal Sparing Approach After Neoadjuvant Therapy in Patients with Rectal Cancer: The Preliminary Results of the ReSARCh Trial.
    Marchegiani F; Palatucci V; Capelli G; Guerrieri M; Belluco C; Rega D; Morpurgo E; Coco C; Restivo A; De Franciscis S; Aschele C; Perin A; Bonomo M; Muratore A; Spinelli A; Ramuscello S; Bergamo F; Montesi G; Spolverato G; Del Bianco P; Gambacorta MA; Delrio P; Pucciarelli S
    Ann Surg Oncol; 2022 Mar; 29(3):1880-1889. PubMed ID: 34855063
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
    Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.